You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Risk Pregnancy, Sexual Dysfunction, Anxiety Trial in Istanbul

Recruiting
  • High Risk Pregnancy
  • +3 more
    • Istanbul, Sisli, Turkey
      Prof. Dr. Cemil Tascioglu City Hospital
    Nov 8, 2023

    Ultra-high Risk for Psychosis, Clinical High Risk for Psychosis, At-risk Mental State Trial (Metacognitive Training)

    Not yet recruiting
    • Ultra-high Risk for Psychosis
    • +2 more
    • Metacognitive Training
    • (no location specified)
    Apr 23, 2023

    Pregnancy, High Risk Trial in Izmir (Motor imagery, Diaphragmatic breathing)

    Not yet recruiting
    • Pregnancy, High Risk
    • Motor imagery
    • Diaphragmatic breathing
    • İzmir, Turkey
      Health Sciences University İzmir Tepecik Education and Research
    Jul 12, 2023

    Perinatal Outcomes, Preterm Birth, High Risk Pregnancy Trial in Veldhoven (continuous eCTG monitoring using the NFMS)

    Not yet recruiting
    • Perinatal Outcomes
    • +2 more
    • continuous eCTG monitoring using the NFMS
    • Veldhoven, Noord-Brabant, Netherlands
      Maxima Medical Centre
    Nov 22, 2023

    High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)

    Active, not recruiting
    • High-Risk Percutaneous Coronary Intervention
    • The Elevate™ System
    • Tbilisi, Georgia
      Israeli-Georgian Medical Research Clinic "Helsicore"
    Oct 24, 2023

    High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

    Not yet recruiting
    • High-risk Non-muscle Invasive Bladder Cancer
    • (no location specified)
    Oct 25, 2023

    High Risk of Stroke Trial in Hangzhou (Usual Diet advice, ORIENT diet intervention)

    Not yet recruiting
    • High Risk of Stroke
    • Usual Diet advice
    • ORIENT diet intervention
    • Hangzhou, Zhejiang, China
      Second Affilated Hospital of Zhejiang University, School of Medi
    Oct 19, 2023

    Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

    Not yet recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • Smoldering Multiple Myeloma (SMM)
    • (no location specified)
    Nov 17, 2023

    T2D Trial

    Not yet recruiting
    • T2D
      • (no location specified)
      Jul 31, 2023

      Cancer Screening Trial (transvaginal ultrasound and microscale endometrial sampling biopsy)

      Not yet recruiting
      • Cancer Screening
      • transvaginal ultrasound and microscale endometrial sampling biopsy
      • (no location specified)
      Nov 5, 2023

      High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary Trial (VITALYST System)

      Not yet recruiting
      • High-risk Percutaneous Coronary Intervention
      • Heart Disease, Coronary
      • VITALYST System
      • (no location specified)
      Nov 9, 2023

      Placental Fetal Growth Restriction in High Risk Population

      Recruiting
      • Fetal Growth Retardation
        • Shanghai, Shanghai, China
          Shanghai First Maternity and Infant Hospital
        Oct 23, 2023

        Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

        Not yet recruiting
        • Liver Transplant; Complications
        • +3 more
        • multi-kinase inhibitors in combination with bevacizumab
        • Beijing, Beijing, China
          Chinese Academy of Medical Sciences & Peking Union Medical Colle
        Sep 11, 2023

        High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)

        Recruiting
        • High-Risk Localized Soft Tissue Sarcoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Apr 20, 2023

        Anesthesia, Blood Pressure, Norepinephrine Trial (Norepinephrine Hydrochloride, Placebo)

        Not yet recruiting
        • Anesthesia
        • +2 more
        • Norepinephrine Hydrochloride
        • Placebo
        • (no location specified)
        Aug 31, 2023

        Early Warning Trial (early warning platform)

        Recruiting
        • High-risk Patients
        • +2 more
        • early warning platform
        • Nanjing, Jiangsu, China
          Zhongda Hospital, Southeast University
        Nov 29, 2022

        Copd Trial in Assiut (HFNC versus NIV)

        Completed
        • Copd
        • HFNC versus NIV
        • Assiut, Egypt
          Doaa Magdy Eid
        Apr 12, 2023

        Healthy Trial (blood sampling)

        Not yet recruiting
        • Healthy
        • blood sampling
        • (no location specified)
        Apr 20, 2023

        Intraoperative Hypotension in High-risk Patients Undergoing

        Recruiting
        • Anesthesia
        • +3 more
          • Siedlce, Mazovian, Poland
            Mazovian Regional Hospital
          May 23, 2023

          Patients With Ultra High Risk of Psychotic Transition Trial in Poitiers (Cerebral MRI with Phosphorus 31 Magnetic Resonance

          Not yet recruiting
          • Patients With Ultra High Risk of Psychotic Transition
          • Cerebral MRI with Phosphorus 31 Magnetic Resonance Spectroscopy
          • Poitiers, France
            Centre Hospitalier Henri Laborit
          May 9, 2023

          Hypertensive Disorder of Pregnancy, Premature Preterm Rupture of Membranes, Preeclampsia Trial in Oslo (Home surveillance of

          Recruiting
          • Hypertensive Disorder of Pregnancy
          • +4 more
          • Home surveillance of pregnancies at risk
          • Oslo, Norway
            Oslo University Hospital
          Mar 9, 2023

          B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

          Not yet recruiting
          • B Acute Lymphoblastic Leukemia
          • +2 more
          • Azacitidine Injection
          • +2 more
          • (no location specified)
          Oct 15, 2023

          High-risk Features of Coronary Lesions in CTA and OCT

          Active, not recruiting
          • Acute Coronary Syndromes
          • Coronary CT angiography
          • Shanghai, Shanghai, China
            Zhongshan Hospital Fudan University
          Oct 13, 2023

          Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

          Not yet recruiting
          • Differentiated Thyroid Cancer
          • Pavia, Lombardia, Italy
            Istituti Clinici Scientifici Maugeri
          May 5, 2023

          Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

          Not yet recruiting
          • Locally Advanced
          • +3 more
          • Guangzhou, Guangdong, China
            Nanfang Hospital Southern Medical University
          May 17, 2023